- 专利标题: Humanized antibodies against Globo H and uses thereof in cancer treatments
-
申请号: US15988875申请日: 2018-05-24
-
公开(公告)号: US10781265B2公开(公告)日: 2020-09-22
- 发明人: Chia-Cheng Wu , Szu-Liang Lai , Yu-Jung Chen , Chih-Yung Hu , Tzu-Yin Lin
- 申请人: Development Center for Biotechnology
- 申请人地址: TW New Taipei
- 专利权人: Development Center for Biotechnology
- 当前专利权人: Development Center for Biotechnology
- 当前专利权人地址: TW New Taipei
- 代理机构: Liang Legal Group, PLLC
- 主分类号: C07K16/34
- IPC分类号: C07K16/34
摘要:
A humanized anti-Globo H antibody, or an scFv or Fab fragment thereof, comprising a heavy-chain variable domain having three complementary regions consisting of HCDR1, HCDR2, and HCDR3 and a light-chain variable domain having three complementary regions consisting of LCDR1, LCDR2, and LCDR3, wherein the sequence of HCDR1 is GYISSDQILN (SEQ ID NO:4), the sequence of HCDR2 is RIYPVTGVTQYXHKFVG (SEQ ID NO:5, wherein X is any amino acid), and the sequence of HCDR3 is GETFDS (SEQ ID NO:6), wherein the sequence of LCDR1 is KSNQNLLX′SGNRRYZLV (SEQ ID NO:7, wherein X′ is F, Y, or W, and Z is C, G, S or T), the sequence of LCDR2 is WASDRSF (SEQ ID NO:8), and the sequence of LCDR3 is QQHLDIPYT (SEQ ID NO:9).
公开/授权文献
信息查询